PUBLICATIONS - New from Clinica Reports - New Devices for Cardiovascular and Heart Disease Volume 2: Management of cardiac rhythm disorders and end-stage cardiac disease
This article was originally published in Clinica
Executive Summary
At the dawn of the new millennium, cardiovascular disease (CVD) remains the leading cause of premature death and morbidity in the industrialised nations. World Health Organisation (WHO) statistics show that in 1999 approximately 17 million deaths worldwide were attributable to CVD, of which 9 million were in the developed nations of the world.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.